Suchergebnisse - "Kapse, Dhananjay"

PubPharm (12)

1

Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) : 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults

enthalten in: Human vaccines & immunotherapeutics | 2024

von Kulkarni, P. | Padmapriyadarsini, C. | Vekemans, J. | +29

2

A Phase 2/3 observer-blind, randomized, controlled study to determine the safety and immunogenicity of SARS-CoV-2 recombinant spike protein vaccine in Indian children and adolescents aged 2 to 17 years

enthalten in: bioRxiv.org | 2023

von Gunale, B. | Kapse, D. | Kar, S. | +23

3

A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults

enthalten in: Scientific reports | 2023

von Kulkarni, P. | Gunale, B. | Kohli, S. | +41

4

Safety and Immunogenicity of SARS-CoV-2 Recombinant Spike Protein Vaccine in Children and Adolescents in India : A Phase 2-3 Randomized Clinical Trial

enthalten in: JAMA pediatrics | 2023

von Gunale, B. | Kapse, D. | Kar, S. | +50

5

Active safety surveillance of rabies monoclonal antibody and rabies vaccine in patients with category III potential rabies exposure

enthalten in: The Lancet regional health. Southeast Asia | 2023

von Kang, G. | Lakhkar, A. | Bhamare, C. | +7

6

Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and Gambia

enthalten in: The New England journal of medicine | 2023

von Haidara, F. | Umesi, A. | Sow, S. | +30

CommentIn: N Engl J Med. 2023 Aug 10;389(6):577. - PMID 37590458

7

Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study

enthalten in: The Lancet regional health. Southeast Asia | 2023

von Kulkarni, P. | Kadam, A. | Godbole, S. | +81

8

Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies : a randomised, phase 2 non-inferiority double-blind controlled trial

enthalten in: The Lancet. Infectious diseases | 2022

von Cotton, M. | Madhi, S. | Luabeya, A. | +23

CommentIn: Lancet Infect Dis. 2022 Oct;22(10):1404-1406. - PMID 35772448

9

A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India

enthalten in: EClinicalMedicine | 2021

von Kulkarni, P. | Padmapriyadarsini, C. | Vekemans, J. | +29

10

Meningococcal Serogroup ACWYX Conjugate Vaccine in Malian Toddlers

enthalten in: The New England journal of medicine | 2021

von Tapia, M. | Sow, S. | Naficy, A. | +16